These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27542275)

  • 1. Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging.
    Tang X; Wu D; Gu LH; Nie BB; Qi XY; Wang YJ; Wu FF; Li XL; Bai F; Chen XC; Xu L; Ren QG; Zhang ZJ
    Oncotarget; 2016 Sep; 7(36):57556-57570. PubMed ID: 27542275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin changes at the early stage of 5XFAD mice.
    Gu L; Wu D; Tang X; Qi X; Li X; Bai F; Chen X; Ren Q; Zhang Z
    Brain Res Bull; 2018 Mar; 137():285-293. PubMed ID: 29288735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and EEG changes in male 5xFAD mice.
    Schneider F; Baldauf K; Wetzel W; Reymann KG
    Physiol Behav; 2014 Aug; 135():25-33. PubMed ID: 24907698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
    Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
    Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dorsal hippocampal changes in T2 relaxation times are associated with early spatial cognitive deficits in 5XFAD mice.
    Tang X; Wu D; Yao Y; Gu L; Chen X; Ren Q; Zhang Z
    Brain Res Bull; 2019 Nov; 153():150-161. PubMed ID: 31422072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
    J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhen J; Qian Y; Fu J; Su R; An H; Wang W; Zheng Y; Wang X
    Front Neural Circuits; 2017; 11():48. PubMed ID: 28713248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer's disease.
    O'Leary TP; Robertson A; Chipman PH; Rafuse VF; Brown RE
    Behav Brain Res; 2018 Jan; 337():256-263. PubMed ID: 28890389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatments with a 5-HT
    Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
    Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice.
    Kanno T; Tsuchiya A; Nishizaki T
    Behav Brain Res; 2014 Nov; 274():302-6. PubMed ID: 25172181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.